Pulmonary Cell News Volume 9.45 | Nov 19 2020

    0
    48








    2020-11-19 | PULCN 9.45


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 9.45 – 19 November, 2020
    TOP STORY

    Engineered
    Mutant α-ENaC Subunit mRNA Delivered by Lipid Nanoparticles Reduces Amiloride Currents in Cystic Fibrosis–Based Cell and Mice Models

    Researchers inhibited endogenous heterotrimeric ENaC channels by introducing inactivating mutant ENaC α mRNA.
    [Science Advances]

    Full Article


    Request a copy of the COVID-19 wallchart.
    PUBLICATIONSRanked by the impact factor of the journal

    Scutellarin
    Ameliorates Pulmonary Fibrosis through Inhibiting NF-κB/NLRP3-Mediated Epithelial–Mesenchymal Transition and Inflammation

    Investigators discovered that scutellarin suppressed inflammation and epithelial–mesenchymal transition in BLM-induced pulmonary fibrosis through NF-κB/NLRP3 signaling.
    [Cell Death & Disease]

    Full Article

    SARS-CoV-2
    Receptor Is Co-Expressed with Elements of the Kinin–Kallikrein, Renin–Angiotensin and Coagulation Systems in Alveolar Cells

    Researchers assembled a healthy human lung cell atlas meta-analysis with ~ 130,000 public single-cell transcriptomes and showed that key elements of the bradykinin, angiotensin and coagulation systems were co-expressed with angiotensin converting enzyme-2 (ACE2) in alveolar cells and associated with their differentiation dynamics, which could explain how changes in ACE2 promoted by SARS-CoV-2 cell entry result in the development of the three most severe clinical components of COVID-19.
    [Scientific Reports]

    Full Article

    ADAM17 Deficiency Protects against Pulmonary Emphysema

    Histological, immunohistochemical, immunofluorescence and molecular analyses, as well as lung function tests, were performed to assess pulmonary emphysema, inflammation and alveolar cell apoptosis.
    [American Journal of Respiratory Cell and Molecular Biology]

    Abstract

    Altered
    Transcriptional and Chromatin Responses to Rhinovirus in Bronchial Epithelial Cells from Adults with Asthma

    Scientists demonstrated that cultured primary bronchial epithelial cells from adults with asthma showed different transcriptional and chromatin responses to rhinovirus infection compared to those without asthma.
    [Communications Biology]

    Full Article

    LUNG CANCER

    AMG
    757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small Cell Lung Cancer

    AMG 757 efficacy was evaluated in small cell lung cancer (SCLC) cell lines and in orthotopic and patient-derived xenograft mouse SCLC models. Following AMG 757 administration, changes in tumor volume, pharmacodynamic changes in tumor-infiltrating T cells (TILs), and the spatial relationship between the appearance of TILs and tumor histology were examined. Tolerability was assessed in nonhuman primates.
    [Clinical Cancer Research]

    Abstract

    OTUD7B
    Suppresses Smac Mimetic-Induced Lung Cancer Cell Invasion and Migration via Deubiquitinating TRAF3

    Scientists assessed lung cancer cell elongation, invasion and migration under treatment with the Smac mimetic LCL161. Functional analyses were performed to detect the contribution of NIK and OTUD7B to LCL161-induced cell invasion and migration. The role of OTUD7B in regulation of the TRAF3/NIK/NF-κB pathway under LCL161 treatment was analysed by immunoblotting, immunoprecipitation, luciferase and ubiquitin assays, shRNA silencing and plasmid overexpression.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    A Fusion of CD63–BCAR4
    Identified in Lung Adenocarcinoma Promotes Tumorigenicity and Metastasis

    Based on the analysis of RNA-sequencing data, investigators identified a fusion transcript of CD63–breast cancer anti-oestrogen-resistance 4 (BCAR4) in a Korean patient with lung adenocarcinoma who did not harbour any known activating mutations in EGFR and KRAS genes. To investigate the oncogenic effect of CD63–BCAR4, in vitro and in vivo animal experiments were performed.
    [British Journal of Cancer]

    Full Article

    TGFβ Promotes YAP‐Dependent AXL
    Induction in Mesenchymal‐Type Lung Cancer Cells

    Researchers revealed that the YAP signature, which was highly enriched in mesenchymal‐type lung cancer, was closely correlated to AXL expression in 181 lung cancer cell lines. Moreover, using isogenic lung cancer cell pairs, they also found that doxorubicin treatment induced YAP nuclear translocation in mesenchymal‐type lung cancer cells to induce AXL expression.
    [Molecular Oncology]

    Abstract


    On-demand Webinar on Studying Cystic Fibrosis using Primary Human Nasal Epithelial Cells - Watch Now
    REVIEWS

    CRISPR-Cas
    Deployment in Non-small Cell Lung Cancer for Target Screening, Validations, and Discoveries

    The authors review the application of CRISPR-Cas in non-small cell lung cancer (NSCLC) for development of mutant models, drug screening, target validation, novel target discoveries, and other emerging potential applications
    [Cancer Gene Therapy]

    Abstract

    INDUSTRY AND POLICY NEWS

    BeiGene
    Announces that RATIONALE 303 Trial of Tislelizumab in Non-Small Cell Lung Cancer Met the Primary Endpoint of Overall Survival at Interim Analysis

    BeiGene, Ltd. announced that the RATIONALE 303 trial of its anti-PD-1 antibody tislelizumab versus docetaxel in the second- or third-line setting in patients with locally advanced or metastatic non-small cell lung cancer who progressed on prior platinum-based chemotherapy, met its primary endpoint of overall survival in the intention-to-treat patient population at the planned interim analysis.
    [Beigene Ltd.]

    Press Release

    FEATURED EVENT

    The
    Evolving Tumor Microenvironment In Cancer Progression: Mechanisms and Emerging Therapeutic Opportunities

    January 9 – January 12, 2021
    Lake Buena Vista, Florida, United States


    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Associate – Idiopathic Pulmonary Fibrosis

    University of North Carolina – Chapel Hill, North Carolina, United States

    Postdoctoral Research Position and PhD Position – Cardiovascular and Lung Diseases

    Max Planck Institute for Heart and Lung Research – Bad Nauheim, Germany

    Faculty
    Position – Oncology & Lung Cancer

    Fred Hutchinson Cancer Research Center – Seattle, Washington, United States

    Assistant
    Professor – Respirologist

    University of Saskatchewan – Saskatoon, Saskatchewan, Canada

    Postdoctoral Fellow – Pharmacogenomics and Integrative Genomics

    University of California, San Diego – La Jolla, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Pulmonary Cell News
    Archives Contact Us
    Pulmonary Cell News Twitter